The combination of influenza, COVID-19, and respiratory syncytial virus (RSV) severely strained hospitals this winter.
Although many people infected with these airborne viruses will recover, many develop pneumonia and require hospital treatment.
Pneumonia is an infection of the lungs that viruses, bacteria, or fungi can cause. And it causes air sacs to fill up, making it harder to breathe and for organs to get enough oxygen.
Tri-demic Surged Pneumonia Cases in 2023
First-in-Human Marburg Vaccine Study Shows Promise
The peer-review journal Lancet recently published a study that found a vaccine candidate targeting the Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.
The vaccine known as cAd3-Marburg vaccine, developed by researchers at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), could become an essential tool if approved to respond to future Marburg virus outbreaks.
Booster Cuts COVID-19-Related Mortality in Adults With Chronic Conditions
For adults with two or more chronic conditions, booster dose of BNT162b2 or CoronaVac linked to reduction in mortality
Wait Time Disparities Increased for VA Care During the Pandemic
Wait time disparities most significant for orthopedic services for both Black and Hispanic veterans
Long COVID Explored in University Settings
Higher prevalence seen among those with underlying conditions, not fully vaccinated, former/current smokers
COVID-19 Pandemic at a Tipping Point: WHO
Organization’s International Health Regulations Emergency Committee met last week to discuss COVID-19